SenesTech

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. It offers its ContraPest product to residential, and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

SenesTech reports record revenue growth driven by Evolve product launch

SenesTech's Q1 2024 performance was driven by the successful launch of Evolve, leading to record revenue growth. The company's strengths lie in expanding distribution channels and focusing on operational efficiencies. Challenges include achieving positive cash flow and balancing sales channels, while opportunities exist in capturing a larger market share with Evolve mouse and leveraging the Amazon store launch.

SenesTech achieves record revenue and margin growth, eyes global expansion

SenesTech delivered strong financial performance with record revenue and improved margins.
The company's product portfolio and expansion strategies position it for continued growth.
Challenges include maintaining profitability, managing competition, and balancing growth with financial stability.
Opportunities exist in market penetration, partnerships, and global expansion initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The firm focuses on rat populations through fertility control. It offers its ContraPest product to residential and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.

SenesTech, Inc. (NASDAQ:SNES ) Q3 2023 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Robert Blum - Lytham Partners, IR Joel Fruendt - Chief Executive Officer Tom Chesterman - Chief Financial Officer Conference Call Participants Operator Good afternoon. And welcome to the SenesTech Reports Third Quarter Fiscal Year 2023 Financial Results Conference Call.

SenesTech, Inc. (SNES) Q3 2023 Earnings Call Transcript

Revenue Growth Up 44%; Net Loss Improved by Almost $700,000 Company to Begin Shipments of Evolve Soft Bait Next Week Expected to Be a Key Driver of Revenue Growth PHOENIX , Nov. 9, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced financial results for the third quarter of 2023. "We accelerated our growth trajectory during the third quarter with strong 44% year-over-year growth in revenues driven by the initiatives we have undertaken to drive sales, improve our product quality, and expand our product options," commented Joel Fruendt, SenesTech's President and Chief Executive Officer.

SenesTech Announces Third Quarter 2023 Financial Results

Financial results to be released after market close;Conference call to be conducted at 5:00 pm ET PHOENIX , Nov. 2, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2023, ended September 30, 2023, after the market close on Thursday, November 9, 2023. The Company has scheduled a conference call that same day, Thursday, November 9, 2023, at 5:00 pm ET, to review the results.

SenesTech to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

The first and only soft bait product featuring breakthrough, next generation technology that targets rodent populations by using nonlethal methods to restrict fertility. PHOENIX , Nov. 1, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, announces today the Company is now taking orders from commercial customers for Evolve™ Soft Bait ("Evolve™"), a solution designed to reduce fertility in rats, for shipment on or before November 13 th.

SenesTech Taking Orders for Evolve™ Soft Bait for Rodent Fertility Control

The first and only soft bait product featuring breakthrough, next generation technology that targets rodent populations by using nonlethal methods to restrict fertility. PHOENIX , Oct. 17, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, announces the launch of EvolveTM Soft Bait ("Evolve"), a solution designed to reduce fertility in rats.

SenesTech Launches Evolve™ Soft Bait for Rodent Fertility Control

PHOENIX , Oct. 9, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) today announced that Joel Fruendt, Chief Executive Officer, and Tom Chesterman, Chief Financial Officer, will present and host one-on-one meetings with investors at the Lytham Partners Fall 2023 Investor Conference, taking place virtually on October 17, 2023. Company Webcast The Company's webcast presentation will be available for viewing at 7:00am ET on Tuesday, October 17, 2023, on the Company's website at https://senestech.investorroom.com/ or https://wsw.com/webcast/lytham9/snes/2056680.

SenesTech to Participate in the Lytham Partners Fall 2023 Investor Conference

PHOENIX , Sept. 11, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced that ContraPest is being deployed into a new vertical, waste water treatment facilities, with deployments in both Washington and California.

ContraPest® Deploying at Waste Water Treatment Facilities

Isolate Bait System™ Now Shipping PHOENIX , Aug. 29, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today the closing of its previously announced exercise of certain existing warrants to purchase 2,934,575 shares of its common stock at a reduced exercise price of $0.7202 per share. In addition, the Company issued new warrants, as described below.

SenesTech Announces Closing of Warrant Exercise for $2.1 Million in Gross Proceeds

SenesTech, Inc. (NASDAQ:SNES ) Q2 2023 Earnings Conference Call August 10, 2023 5:00 PM ET Company Participants Robert Blum - Lytham Partners Joel Fruendt - Chief Executive Officer Tom Chesterman - Chief Financial Officer Conference Call Participants Amit Dayal - H.C. Wainwright Tucker Andersen - Above All Advisors Operator Good afternoon, everyone and welcome to the SenesTech, Inc. Reports Second Quarter Fiscal Year 2023 Financial Results Conference Call.

SenesTech, Inc. (SNES) Q2 2023 Earnings Call Transcript

July 2023 Sales Increased 126% as New Initiatives Take Hold Expanded Product Offerings Expected to Drive Future Growth PHOENIX , Aug. 10, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced financial results for the second quarter of 2023 for the period ended June 30, 2023. "We successfully executed against a number of key strategic imperatives to drive long-term growth in ContraPest, resulting in continued growth in revenues during the second quarter," commented Joel Fruendt, SenesTech's President and Chief Executive Officer.

SenesTech Announces Second Quarter 2023 Financial Results

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX , Aug. 3, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its second quarter 2023, ended June 30, 2023, after the market close on Thursday, August 10, 2023. The Company has scheduled a conference call that same day, Thursday, August 10, 2023, at 5:00 pm ET, to review the results.

SenesTech to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023

Single step deployment system increases market potential  while reducing install times by 80% Incorporates Enhanced ContraPest Formulation for  Improved Performance in the Field PHOENIX , July 24, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced the launch of a new delivery system for ContraPest®, the Isolate Bait System™. This system also incorporates an enhanced formulation of ContraPest that is expected to provide improved performance of the fertility control bait in the field.

SenesTech Launches Isolate Bait System™ for Contrapest®

NSPCA is also working on recommending SenesTech's (SNES) ContraPest to private and state entities and to assist with regulatory issues.

SenesTech (SNES) New Alliance to Aid Expansion in South Africa

Further Expansion in the Region is Contemplated in the Agreement PHOENIX , June 5, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced entry into a Distribution Agreement with Pesterminators Pvt Ltd of Maldives ("Pesterminators") for the deployment of ContraPest® into Maldives. As Pesterminators is part of an multinational pest control organization, the potential expansion of the agreement throughout the region is contemplated in the agreement.

SenesTech Announces Distribution Agreement and Initial Order for ContraPest® in Maldives

PHOENIX , June 1, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced entry into a Development and Distribution Agreement with Pathogens and Environmental Solutions (PES) of South Africa for the commercialization of ContraPest® into South Africa. Under the agreement, PES will be responsible for seeking regulatory registration, and all marketing and sales of ContraPest into South Africa.

SenesTech Announces Development and Distribution Agreement for ContraPest® in South Africa

PHOENIX , May 15, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced Joel Fruendt, CEO, will participate in a fireside chat and host one-on-one meetings with investors at the Lytham Partners Spring 2023 Investor Conference, taking place virtually on May 18, 2023. Company Webcast The Company's webcasted fireside chat will be available for viewing at 9:00am ET on Thursday, May 18, 2023, on the Company's website at http://senestech.investorroom.com/ or https://wsw.com/webcast/lytham8/snes/2055375.

SenesTech to Participate at Lytham Partners Spring 2023 Investor Conference on May 18, 2023

E-Commerce Leads Growth at 54% Year Over Year PHOENIX , May 11, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced the first quarter of 2023 financial results. Joel Fruendt, SenesTech's President and Chief Executive Officer, commented, "We experienced continued growth during the first quarter of 2023, led by strong growth in the e-Commerce segment.

SenesTech Announces First Quarter 2023 Financial Results

PHOENIX , May 8, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced the deployment of ContraPest® into one of the largest agricultural grain export companies in the world. "20% of the world's stored food supply is lost to rats' consumption and contamination, with estimates over 30% when specifically referring to grain storage and transport.

ContraPest® Deployment Expands to Grain Storage and Transport

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX , May 4, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its first quarter 2023, ended March 31, 2023, after the market close on Thursday, May 11, 2023. The Company has scheduled a conference call that same day, Thursday, May 11, 2023, at 5:00 pm ET, to review the results.

SenesTech to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

PHOENIX , April 24, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, recently concluded participation at PEAK 2023, the largest trade show in the United States focused on poultry. The Midwest Poultry Federation (MPF) was founded in 1971 as a 501(c)6 nonprofit organization and held its first convention in Minneapolis in 1972.

SenesTech Presents ContraPest® At PEAK 2023 Poultry Show

PHOENIX , April 12, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the closing of its previously announced registered direct offering of 857,146 shares of its common stock, at a purchase price of $1.75 per share, priced at-the-market under Nasdaq rules. The Company also issued in a concurrent private placement unregistered Series C warrants (the "Series C Warrants") to purchase up to an aggregate of 857,146 shares of common stock.

SenesTech Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Growth in the Animal Care Segment of Pest Control Continues to Be Strong

SenesTech and ContraPest® Featured at the Animal Care Expo in New Orleans

PHOENIX , April 10, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced that it has entered into a definitive agreement for the purchase and sale of up to an aggregate of 857,146 shares of its common stock (or common stock equivalents in lieu thereof), at a purchase price of $1.75 per share (or common stock equivalent in lieu thereof), in a registered direct offering priced at-the-market under Nasdaq rules. The Company has also agreed to issue in a concurrent private placement unregistered Series C warrants (the "Series C Warrants") to purchase up to an aggregate of 857,146 shares of common stock.

SenesTech Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

PHOENIX , April 5, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced a national distribution agreement with Target Specialty Products for  ContraPest.  In addition to distribution, Target Specialty Products and SenesTech will be actively collaborating in marketing and selling ContraPest throughout its network.

SenesTech Signs a Distribution Agreement with Target Specialty Products for ContraPest®

SenesTech, Inc. (NASDAQ:SNES ) Q4 2022 Results Conference Call March 16, 2023 5:00 PM ET Company Participants Joel Fruendt - CEO Tom Chesterman - CFO Conference Call Participants Avi Fisher - Long Cast Advisors Robert Blum - Lytham Partners Operator Good afternoon and welcome to the SenesTech, Incorporated Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.

News for SenesTech Stock (SNES)